[go: up one dir, main page]

GB0020616D0 - Particulates - Google Patents

Particulates

Info

Publication number
GB0020616D0
GB0020616D0 GB0020616A GB0020616A GB0020616D0 GB 0020616 D0 GB0020616 D0 GB 0020616D0 GB 0020616 A GB0020616 A GB 0020616A GB 0020616 A GB0020616 A GB 0020616A GB 0020616 D0 GB0020616 D0 GB 0020616D0
Authority
GB
United Kingdom
Prior art keywords
particulates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0020616A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Holdings Cambridge Ltd
Original Assignee
Quadrant Holdings Cambridge Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadrant Holdings Cambridge Ltd filed Critical Quadrant Holdings Cambridge Ltd
Priority to GB0020616A priority Critical patent/GB0020616D0/en
Publication of GB0020616D0 publication Critical patent/GB0020616D0/en
Priority to AU2001278622A priority patent/AU2001278622A1/en
Priority to PCT/GB2001/003676 priority patent/WO2002015876A2/en
Ceased legal-status Critical Current

Links

GB0020616A 2000-08-21 2000-08-21 Particulates Ceased GB0020616D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0020616A GB0020616D0 (en) 2000-08-21 2000-08-21 Particulates
AU2001278622A AU2001278622A1 (en) 2000-08-21 2001-08-16 Amorphous carrier materials for drug delivery
PCT/GB2001/003676 WO2002015876A2 (en) 2000-08-21 2001-08-16 Amorphous carrier materials for drug delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0020616A GB0020616D0 (en) 2000-08-21 2000-08-21 Particulates

Publications (1)

Publication Number Publication Date
GB0020616D0 true GB0020616D0 (en) 2000-10-11

Family

ID=9898041

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0020616A Ceased GB0020616D0 (en) 2000-08-21 2000-08-21 Particulates

Country Status (3)

Country Link
AU (1) AU2001278622A1 (en)
GB (1) GB0020616D0 (en)
WO (1) WO2002015876A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833992B2 (en) 2001-05-18 2010-11-16 Merck Sharpe & Dohme Conjugates and compositions for cellular delivery
US8202979B2 (en) 2002-02-20 2012-06-19 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
US7491805B2 (en) 2001-05-18 2009-02-17 Sirna Therapeutics, Inc. Conjugates and compositions for cellular delivery
US7575761B2 (en) 2000-06-30 2009-08-18 Novartis Pharma Ag Spray drying process control of drying kinetics
US7517864B2 (en) 2001-05-18 2009-04-14 Sirna Therapeutics, Inc. RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
US9994853B2 (en) 2001-05-18 2018-06-12 Sirna Therapeutics, Inc. Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
US9657294B2 (en) 2002-02-20 2017-05-23 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
US9181551B2 (en) 2002-02-20 2015-11-10 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
GB0208608D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Composition
GB0210771D0 (en) * 2002-05-10 2002-06-19 Univ London Pharmacy Derivatised particulate inhalation carriers
US10508277B2 (en) 2004-05-24 2019-12-17 Sirna Therapeutics, Inc. Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
WO2006066907A1 (en) * 2004-12-21 2006-06-29 Glaxo Group Limited Pharmaceutical formulations
EP2632472B1 (en) 2010-10-29 2017-12-13 Sirna Therapeutics, Inc. Rna interference mediated inhibition of gene expression using short interfering nucleic acids (sina)
JOP20120023B1 (en) 2011-02-04 2022-03-14 Novartis Ag Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
CA2965759C (en) 2014-10-31 2023-12-12 Glaxosmithkline Intellectual Property Development Limited Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2197982C (en) * 1994-08-04 2010-03-23 Bruce Joseph Roser Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
ZA9711732B (en) * 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
GB9916316D0 (en) * 1999-07-12 1999-09-15 Quadrant Holdings Cambridge Dry powder compositions

Also Published As

Publication number Publication date
AU2001278622A1 (en) 2002-03-04
WO2002015876A2 (en) 2002-02-28
WO2002015876A3 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
EP1423344A4 (en) Micro-granulose particulates
DE60105852D1 (en) Fluidmischsystem
AU3391801A (en) Pyridinylimidazoles
AU8274301A (en) Electro-powder
DE50105205D1 (en) Creatinin-biosensor
AU6803901A (en) Bis-arylsulfones
DE50112740D1 (en) Strangführungselement
GB0020616D0 (en) Particulates
DE50107376D1 (en) Orientierte acrylathotmelts
DE50102859D1 (en) Hochfliessfähige propylenblockcopolymerisate
AU9385201A (en) Sulfonylguanidine
DE50008626D1 (en) Substituierte aminomethyl-phenyl-cyclohexanderivate
AU6619001A (en) Liquid-pourers
DE50114303D1 (en) Nsaugluftkanal
GB0121929D0 (en) Multidirectionalapparatus
DE50008447D1 (en) Aminomethyl-phenyl-cyclohexanonderivate
DE50114375D1 (en) Compound-reibungsvakuumpumpe
AU9187601A (en) Triazolo-epothilones
AU4686401A (en) Hypotensors
DE50100877D1 (en) Thermoverformbares verbundmaterial
DE50006446D1 (en) Otoplastik
AU4831301A (en) Gm-negative ehv-mutants
DE60107852D1 (en) Thienopyrrolidinone
DE50003404D1 (en) Multi-master-bus-system
DE50103809D1 (en) Hydrocephalusventil

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)